SAB Biotherapeutics (SABS) Enters $20M Equity Sales Agreement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
Form 424B5 SAB Biotherapeutics,
January 26, 2024 4:01 PM EST
Filed Pursuant to Rule 424(b)(5)
Registration No. 333-271768
